<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">346505</id>
  <title nil="true"/>
  <common-name>N-[4-[4-(4-chlorophenyl)piperazine-1-carbonyl]phenyl]-3,4,5-trimethoxybenzamide</common-name>
  <description>N-[4-[4-(4-chlorophenyl)piperazine-1-carbonyl]phenyl]-3,4,5-trimethoxybenzamide is a chemical compound with the formula C27H28ClN3O5. With an average molecular weight of 510.00 g/mol, N-[4-[4-(4-chlorophenyl)piperazine-1-carbonyl]phenyl]-3,4,5-trimethoxybenzamide is a heavy molecule.</description>
  <cas>89767-71-5</cas>
  <pubchem-id>56007</pubchem-id>
  <chemical-formula>C27H28ClN3O5</chemical-formula>
  <weight>510</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-31T09:58:54Z</created-at>
  <updated-at type="dateTime">2026-08-31T09:58:54Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>COC1=CC(=CC(=C1OC)OC)C(=O)NC2=CC=C(C=C2)C(=O)N3CCN(CC3)C4=CC=C(C=C4)Cl</moldb-smiles>
  <moldb-formula>C27H28ClN3O5</moldb-formula>
  <moldb-inchi>InChI=1S/C27H28ClN3O5/c1-34-23-16-19(17-24(35-2)25(23)36-3)26(32)29-21-8-4-18(5-9-21)27(33)31-14-12-30(13-15-31)22-10-6-20(28)7-11-22/h4-11,16-17H,12-15H2,1-3H3,(H,29,32)</moldb-inchi>
  <moldb-inchikey>HMGWSBCLOYWQIT-UHFFFAOYSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">509.1717487</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>4.4</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM342398</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>N-[4-[4-(4-chlorophenyl)piperazine-1-carbonyl]phenyl]-3,4,5-trimethoxybenzamide</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Benzenoids</superklass>
  <klass>Benzene and substituted derivatives</klass>
  <subklass>Anilides</subklass>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0296858</sync-id>
  <structure-inchikey>HMGWSBCLOYWQIT-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>100000080004000400000002000000000000400000000000000000100000800000000000002004000000000000000400000000000000000000020000000010100000000000000000000000000010080000050000000100000000000020102000000000000000000000000000040020400000000000000000080000000000000000000000000000000000000000000000000000000084000040000000000000000008000008900000080000010000004010000000000000000000010004000000000000200000000001000008040000000000040000800000400000000000020200000004000000000</structure-fingerprint>
  <structure-pattern-fingerprint>7014c0008d32865081001b608138a2001a00140081052000003d20408224c84c6c020854118000000100490800c00000046002a5c08d32210164643900a04010c7110c011280161000901040027202000804858051211f3340041462400249040c28052f00488220400c1480dd94004d208280500121c1047198044002710202104000180ef0820808060250482c0008391d181244409e8a500308206040008088d3101310b0c02000040960057c37104ac004028941084010000a104cc00212a01002e404d8003201808484541502900c010010434050000d61028028000300901041100881010011000003599220820050043084c2040e1108108052000606</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAkAAAAJwAAAIABBgBgAAAAAQMIACgAAAAD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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:45:13Z</structure-indexed-at>
</compound>
